Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Turner

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|December 21, 2017
Signatures of DNA-Repair Deficiencies in Breast CancerNicholas C Turner
Nature Cancer|February 5, 2022
Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatmentNida Pasha, Nicholas C Turner
Breast Cancer Research and Treatment|February 9, 2011
Biomarkers of PARP inhibitor sensitivityNicholas C Turner, Alan Ashworth
The Lancet. Oncology|June 4, 2017
Targeting PIK3CA-mutant advanced breast cancer in the clinical settingNeha Chopra, Nicholas C Turner
Current Opinion in Oncology|October 9, 2013
Targeting receptor tyrosine kinases in HER2-negative breast cancerGayathri Anandappa, Nicholas C Turner
Cancer Discovery|October 5, 2023
Liquid Biopsies in Breast Milk for the Early Detection of Breast CancerNiamh Cunningham, Nicholas C Turner
Breast Cancer Research : BCR|June 27, 2012
Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancerVikram K Jain, Nicholas C Turner
Methods in Molecular Biology (Clifton, N.J.)|May 3, 2018
Assessing HER2 Amplification in Plasma cfDNAIsaac Garcia-Murillas, Nicholas C Turner
BMJ (Clinical Research Ed.)|July 16, 2008
Management of breast cancer--Part IINicholas C Turner, Alison L Jones
Science Translational Medicine|December 17, 2010
A therapeutic target for smoking-associated lung cancerNicholas C Turner, Michael J Seckl
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|December 21, 2017
Signatures of DNA-Repair Deficiencies in Breast CancerNicholas C Turner
Nature Cancer|February 5, 2022
Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatmentNida Pasha, Nicholas C Turner
Breast Cancer Research and Treatment|February 9, 2011
Biomarkers of PARP inhibitor sensitivityNicholas C Turner, Alan Ashworth
The Lancet. Oncology|June 4, 2017
Targeting PIK3CA-mutant advanced breast cancer in the clinical settingNeha Chopra, Nicholas C Turner
Current Opinion in Oncology|October 9, 2013
Targeting receptor tyrosine kinases in HER2-negative breast cancerGayathri Anandappa, Nicholas C Turner
Cancer Discovery|October 5, 2023
Liquid Biopsies in Breast Milk for the Early Detection of Breast CancerNiamh Cunningham, Nicholas C Turner
Breast Cancer Research : BCR|June 27, 2012
Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancerVikram K Jain, Nicholas C Turner
Methods in Molecular Biology (Clifton, N.J.)|May 3, 2018
Assessing HER2 Amplification in Plasma cfDNAIsaac Garcia-Murillas, Nicholas C Turner
BMJ (Clinical Research Ed.)|July 16, 2008
Management of breast cancer--Part IINicholas C Turner, Alison L Jones
Science Translational Medicine|December 17, 2010
A therapeutic target for smoking-associated lung cancerNicholas C Turner, Michael J Seckl
Pageof 14